Stock Updates

Abbott Laboratories (NYSE: ABT) – Is this large market cap stock undervalued?

Abbott Laboratories (NYSE: ABT), is firmly in the large market cap category with market cap of 62166.3. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Abbott Laboratories is 42.29 (with a change from open of 0.09%), this in conjunction with a target price of 7.42. Volume today has so far reached 5226500, with an average volume of about 9571.18. The GAP for this stock, is -0.19%.

The P/E ratio is 32.46, bringing the forward P/E to a value of 17.23. The current EPS for Abbott Laboratories, is 1.3, with a EPS growth for this year coming to a value of 53.50%. Performance has been interesting with performance year to date coming to -4.07%.

Looking further into the growth statistics for Abbott Laboratories, EPS is looking like it will grow 11.69% in the next year. Looking even further it is projected to be 9.61%. Quarter over quarter is -22.60% for EPS growth and for sales growth quarter over quarter it is 3.20%. Looking at past EPS growth statistics we see that for the past five years it has been -10.30%. Sales growth for the past five years has in fact been -10.30%.

Looking at the ownership, we see that the insider ownership is at 0.30% and institutional ownership is 73.90%. Shares outstanding is 1470, while shares float is at a value of 1465.05. Float short for Abbott Laboratories is 4.41% and the short ratio is 6.75.

In terms of debt, long term debt/equity is 0.29, while the total debt/equity comes to 0.41. The ability to meet these debts, means that the current ratio is 1.5, and the quick ratio is 1.2. The most recent gross margin is 56.90% and their operating margin is 14.00%. The profit margin is 11.10%.

Abbott Laboratories has seen returns on assets of 5.60%, and on investment, 7.70%. Return on equity is 10.90%. Price/Earnings to growth ratio is 3.38. Price/Sales ratio is at a value of 3.02, with Price/book ratio coming to 3.02 and Price/cash is 14.01, and finally Price/Free cash Flow is 307.75.

The simple moving averages are -2.12% and 3.81% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -7.64% and the 52 week low is 18.92%.

Abbott Laboratories has a dividend yield of 2.46%, with a current price of 42.29. The ability to pay this means the payout ratio is 66.50%. This is in an industry, Medical Appliances & Equipment, with equally high dividends from other companies in this sector, which it is Healthcare. Abbott Laboratories is based in USA.

Performance in the Medical Appliances & Equipment industry means that Abbott Laboratories has seen performance for the past week of 0.88%, with performance for the month coming to -2.22%. Looking at the data for the quarter it is at a value of 10.32%, and for the half year the performance is 9.70%. Volatility for this week is 1.26% and for the month this is 1.55%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment